Researchers are constantly looking for a cure for breast cancer, and now a new chemotherapy drug has shown some real progress in the fight against the disease.
According to Reuters, Peregrine Pharmaceuticals has developed a medication that, in clinical trials, let to 74 percent of participants showing at least some sort of positive response.
In a study period that lasted six months, 34 patients experienced significant tumor reduction, while nine percent went into complete remission. These are incredibly uplifting statistics, and Peregrine plans to present its findings at a meeting of the American Society of Clinical Oncology next month.
The drug, called Bavituximab, is an antibody that is specifically designed to build a patient's immune system. It cures the disease by fighting off tumors and its blood vessels.
According to the National Cancer Institute, side effects from chemotherapy can include nausea, fatigue and constipation. However, breast cancer patients should rest assured that there are other medications your doctor can prescribe to combat these ailments.